Tag: life sciences
-
FDA to Test New Trial Designs, Assess A.I. Models
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics.
-
Genomics-Blockchain Company Launches, Raises $4.3 Million
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing.
-
Non-Invasive Imaging Technology Probes Deeper Into Tissue
An imaging process that combines ultrasound and lasers is shown in tests with lab samples and in animals to provide clearer and more detailed images of tissue deeper in the body.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
A.I., Imaging Shown to Predict Immunotherapy Success
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.
-
UPDATE: 23andMe Shuts Down Open API Access to Raw Data
The personal genetics company 23andMe is closing down access to its raw genomic data for independent software developers.
-
Graphene Extended for 3-D Printing, Medical Devices
Two recent studies describe methods for fabricating the material graphene into complex shapes with 3-D printing, as well as showing graphene can likely degrade inside the human body.
-
Hand-Held Device Inspects Individual Retina Cells
A medical engineering team created a small lightweight device that can inspect individual photoreceptor cells in the retina, the part of the eye that converts visual images to brain signals.
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.